Status:
COMPLETED
Apexification Treatment With MTA(Mineral Trioxide Aggregate) and Ca(OH)2
Lead Sponsor:
Ege University
Conditions:
Immature Teeth
Eligibility:
All Genders
16-40 years
Phase:
NA
Brief Summary
Ninety immature teeth with necrotic pulps and periapical lesions on patients (aged 16-40y) were treated with AT using MTA (45 teeth) or CH (45 teeth) between 2015 and 2018. The patients were contacted...
Detailed Description
The aim of the study was to evaluate and compare the influence of various predictors on outcomes of apexification treatment (AT) using either mineral trioxide aggregate (MTA) or calcium hydroxide (CH)...
Eligibility Criteria
Inclusion
- patients without a systemic disease and compromised immune status
- patients had immature teeth with periapical lesions with or without previous endodontic treatment.
Exclusion
- patients with advanced periodontitis (more than 5 mm periodontal attachment and bone loss),
- teeth with contraindications for endodontic treatment (root fracture, unrestorable tooth, replacement resorption or previous surgical endodontic treatment).
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03855501
Start Date
January 1 2015
End Date
February 1 2019
Last Update
February 28 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.